While earlier studies, such as Ma, T. et al., have linked SALL2 expression to unfavorable outcomes in rectal cancer [46], our CRC dataset was primarily composed of colon cancer cases (44 out of 48 colorectal cancer instances), with only a small number of rectal cancer cases (n = 4), limiting any significant site-specific comparison. The gene discussed is SALL2; the disease is rectal cancer.